Oklo Inc. (NYSE:OKLO – Get Free Report) shares were down 6.2% on Wednesday following a dissappointing earnings announcement. The stock traded as low as $56.68 and last traded at $56.7510. Approximately 11,811,851 shares were traded during mid-day trading, an increase of 10% from the average daily volume of 10,699,205 shares. The stock had previously closed at $60.53.
The company reported ($0.27) EPS for the quarter, missing analysts’ consensus estimates of ($0.17) by ($0.10). During the same quarter in the prior year, the business posted ($0.74) earnings per share.
Key Oklo News
Here are the key news stories impacting Oklo this week:
- Positive Sentiment: DOE and NRC approvals advance commercial path — Oklo’s Atomic Alchemy unit received an NRC materials license and the DOE approved Nuclear Safety Design Agreements for Oklo’s pilot reactors, accelerating isotope production and reactor deployment prospects. Business Wire: DOE NSDA for Groves Isotopes Test Reactor
- Positive Sentiment: First NRC license opens near-term revenue avenue — The NRC license to process isotopes through Atomic Alchemy creates an early commercial revenue stream (isotope sales) separate from reactor deployment. Yahoo: Atomic Alchemy Granted NRC License
- Positive Sentiment: High-profile media coverage and CEO interviews are keeping investor interest alive around Oklo’s strategy and timelines. CNBC: Full Interview with Oklo CEO
- Neutral Sentiment: Some brokers still show conviction — a mix of reaffirmations and high price targets remain (e.g., Cantor Fitzgerald’s $122 PT), highlighting divergent analyst views that can sustain volatility. Benzinga: Analyst Coverage
- Neutral Sentiment: MarketBeat analysis notes dilution pressure eases in 2026 and institutional ownership is high — structural support exists, but payoff depends on execution and timing. MarketBeat: Oklo coverage and analysis
- Negative Sentiment: Q4 earnings missed expectations — Oklo reported a wider loss per share (‑$0.27 vs. consensus ‑$0.17), reinforcing concerns about near-term cash burn for a pre‑revenue company. MarketBeat: Q4 results & call
- Negative Sentiment: Multiple same‑day analyst price‑target reductions — Goldman Sachs, Citigroup and others trimmed targets today (Goldman to $65, Citi to $73.50, Needham/Canaccord cut targets), increasing short‑term downside as models are re‑priced. Benzinga: Analyst target changes TickerReport: Citi target cut
- Negative Sentiment: Large insider selling reported (CEO and CFO dispositions) — senior insider sales disclosed this week (blocks at roughly $60) have amplified selling pressure and raised investor concern about near‑term conviction. Blockonomi: Analysts cut targets and insiders offload
Analyst Upgrades and Downgrades
Read Our Latest Research Report on OKLO
Insiders Place Their Bets
In related news, CEO Jacob Dewitte sold 840,000 shares of the company’s stock in a transaction on Monday, December 22nd. The stock was sold at an average price of $82.32, for a total transaction of $69,148,800.00. Following the transaction, the chief executive officer directly owned 1,580,000 shares of the company’s stock, valued at approximately $130,065,600. The trade was a 34.71% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Richard Craig Bealmear sold 72,090 shares of the stock in a transaction dated Friday, March 13th. The stock was sold at an average price of $60.00, for a total value of $4,325,400.00. Following the completion of the sale, the chief financial officer directly owned 386,008 shares of the company’s stock, valued at approximately $23,160,480. This represents a 15.74% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 2,067,583 shares of company stock worth $170,285,400 in the last quarter. 18.90% of the stock is currently owned by corporate insiders.
Institutional Trading of Oklo
Hedge funds have recently made changes to their positions in the stock. Armstrong Advisory Group Inc. acquired a new position in Oklo in the 3rd quarter valued at approximately $27,000. Gables Capital Management Inc. acquired a new stake in shares of Oklo during the 3rd quarter valued at $28,000. Nemes Rush Group LLC purchased a new position in shares of Oklo during the 3rd quarter valued at $28,000. CI Investments Inc. grew its holdings in shares of Oklo by 153.0% during the 3rd quarter. CI Investments Inc. now owns 296 shares of the company’s stock valued at $33,000 after acquiring an additional 179 shares in the last quarter. Finally, Whittier Trust Co. of Nevada Inc. acquired a new position in shares of Oklo in the third quarter worth $33,000. 85.03% of the stock is owned by hedge funds and other institutional investors.
Oklo Stock Down 6.2%
The stock’s 50 day moving average price is $75.08 and its two-hundred day moving average price is $95.27. The firm has a market capitalization of $8.87 billion, a price-to-earnings ratio of -105.09 and a beta of 0.80.
Oklo Company Profile
Oklo, Inc is a California-based energy technology company specializing in the design and development of advanced nuclear microreactors. Headquartered in Fremont, the firm focuses on small modular reactor (SMR) technology that leverages fast-neutron fission and liquid-metal cooling to deliver carbon-free power. Oklo’s core objective is to bring compact, factory-built reactors online within a decade, offering a low-footprint alternative to traditional large nuclear plants.
The company’s flagship product, the Aurora microreactor, is a 1.5-megawatt electric (MWe) fast reactor cooled by a sodium alloy.
Read More
Receive News & Ratings for Oklo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oklo and related companies with MarketBeat.com's FREE daily email newsletter.
